Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlook

Go back to Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlook
(NASDAQ: EOLS) Delayed: 6.56 -0.07 (1.06%)
Previous Close $6.63    52 Week High
Open $6.56    52 Week Low
Day High $6.68    P/E N/A 
Day Low $6.54    EPS
Volume 52,290